Skip to main content
OpenTrials
Completed

NCT Number: NCT02385435

Caudal Bupivacaine vs Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Children

The aim of this prospective randomized double-blind study was to compare the analgesic efficacy and the side effects of two doses of dexmedetomidine (1 and 2 µg.kg-1) co-administered with bupivacaine with bupivacaine alone for caudal analgesia in children undergoing infra-umbilical surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

About this study

  • Quality assurance plan for data validation and registry: After Data was registered, it was reviewed by a second person who compared it to the Data in patient data collection forms.
  • Data check: carried out using Statistical Package for the Social Sciences (SPSS) variable definition protocols. Also data were entered in EXCEL sheets for comparisons to guarantee consistency.
  • Source data verification: Paper case report forms and medical records.
  • Standard Operating Procedures to address registry operations and analysis activities: Eligible patients were recruited after obtaining consent. Data was collected by qualified personnel rained on the process. Data was entered into Excel sheets and SPSS programs and compared for consistency. Analysis of Data was carried out by a qualified statistician. Adverse events were reported as yes/no variables. Data of patients who had Change in management was omitted from analysis.
  • Sample size assessment: Sample size was calculated to detect a 65% reduction in the analgesic requirement during the first 24 h from 75% in the bupivacaine group with α= 0.05 and β=0.80.
  • Plan for missing data: Patients with missing Data were omitted from statistical analysis.
  • Statistical analysis plan: carried out using International Business Machines (IBM) statistics 19.0 statistical package for windows. Data were compared using analysis of variance for continuous variables, Kruskal-Wallis test for ordinal, and chi square test for categorical ones. Post hoc analyses were carried out as appropriate.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with American Society of Anesthesiologists (ASA) - I
  • Scheduled for lower abdominal and perineal surgery
  • Under general anesthesia

Exclusion criteria

  • history of developmental delay or mental retardation
  • known or suspected coagulopathy or recent use of anticoagulant/antiplatelet drugs.
  • known allergy to any of the study drugs.
  • any signs of infection or congenital abnormalities at the site of the proposed caudal block

Treatment and study plan

Bupivacaine

Drug

Caudal Bupivacaine 2 mg/kg single shot

Other names: Broup B

dexmedetomidine 1μg.kg-1

Drug

Caudal dexmedetomidine 1μg.kg-1, single shot

Other names: Group BD1

dexmedetomidine 2μg.kg-1

Drug

Caudal dexmedetomidine 2μg.kg-1, single shot

Other names: Group BD2

Primary outcomes

  1. Time to first analgesic requirement

    Time frame: 24 hours

    The time from end of surgery to the first requirement of postoperative analgesia

  2. Postoperative pain scores

    Time frame: 24 hours

  3. Number of postoperative analgesia doses

    Time frame: 24 hours

    Number of paracetamol doses needed by each patient

Secondary outcomes

  1. Postoperative sedation scores

    Time frame: 2 hours

    Level of sedation was recorded throughout the post-anesthesia care unit stay at 15-minute time intervals.

  2. Sevoflurane concentration

    Time frame: intraoperative

    Sevoflurane concentration required to maintain Bispectral Index (BIS) monitor reading between 40 and 60%.

  3. Blood pressure

    Time frame: intraoperative

    Intraoperative blood pressure readings

  4. Heart Rate

    Time frame: intraoperative

    Intraoperative heart rate readings

  5. Side effects of study drugs

    Time frame: 24 hours

    Any side effects of study drugs in the first 24 hours postoperative hours were recorded (nausea, Vomiting, urine retention, lower limb weakness and emesis).

Sponsors and collaborators

Lead sponsor

University of Jordan

Other

Registry information

Official study title

Comparison of Caudal Bupivacaine Alone With Bupivacaine Plus Two Doses of Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Infra-umbilical Surgery: A Randomized Controlled Double Blinded Study

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Mar 11, 2015
Registry last updated
Mar 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.